On November 21, 2016, the U.S. Court of Appeals for the First Circuit upheld a 2014 jury verdict for AstraZeneca (AZ) and Ranbaxy regarding a 2012 payment of $700 million from AstraZeneca for Ranbaxy to abandon its challenge...more
12/5/2016
/ Antitrust Violations ,
Appeals ,
Generic Drugs ,
Hatch-Waxman ,
Jury Verdicts ,
Pay-For-Delay ,
Pharmaceutical Patents ,
Popular ,
Reverse Payment Settlement Agreements ,
Rule-of-Reason Analysis ,
Summary Judgment
Unitary patents in Europe -
The European unitary patent and Unitary Patent Court (UPC) are slated to go into effect in early 2017. These monumental changes will have a significant impact on the ways patent rights are...more
9/7/2016
/ Biotechnology ,
EU ,
European Patent Convention ,
European Patent Office ,
Intellectual Property Protection ,
Member State ,
Patent Cooperation Treaty ,
Patents ,
Popular ,
Supplementary Protection Certificate ,
UK Brexit ,
Unified Patent Court ,
Unitary Patent